G D Batty1, F Barzi2, M Woodward3, K Jamrozik4, J Woo5, H C Kim6, H Ueshima7, R R Huxley2. 1. Medical Research Council Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK; The George Institute for International Health, University of Sydney, Sydney, Australia. Electronic address: david-b@sphsu.mrc.ac.uk. 2. The George Institute for International Health, University of Sydney, Sydney, Australia. 3. The George Institute for International Health, University of Sydney, Sydney, Australia; Mount Sinai Medical Center, New York, NY, USA. 4. School of Population Health and Clinical Practice, University of Adelaide, Adelaide, Australia. 5. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, The People's Republic of China. 6. Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea. 7. Department of Health Science, Shiga University of Medical Science, Shiga, Japan.
Abstract
BACKGROUND: The observation that taller people experience an increased risk of selected cancers is largely restricted to Caucasian cohorts. These associations may plausibly differ in Asian populations. For the first time, we make direct comparison in the same analyses of the associations between height and a series of malignancies in Australasian (Caucasian) and Asian populations. METHODS: Analyses were based on the Asia Pacific Cohort Studies Collaboration of 506 648 study participants (408 381 Asia, 98 267 Australasia) drawn from 38 population-based cohort studies. Cox proportional hazards regression was used to estimate the relationship between height and cancer rates. RESULTS: A total of 3 272 600 person-years of follow-up gave rise to 7497 cancer deaths (4415 in Asia; 3082 in Australasia). After multiple adjustments and left censoring, taller individuals experienced increased rates of carcinoma of the intestine (men and women); all cancers, liver, lung, breast, 'other' malignancies (all women); and cancers of the prostate and bladder (men). No consistent regional (Asia versus Australasia) or sex differences were observed. CONCLUSIONS: In the present study, taller men and women had an elevated risk of selected malignancies. These associations did not differ appreciably between Asian and Caucasian populations.
BACKGROUND: The observation that taller people experience an increased risk of selected cancers is largely restricted to Caucasian cohorts. These associations may plausibly differ in Asian populations. For the first time, we make direct comparison in the same analyses of the associations between height and a series of malignancies in Australasian (Caucasian) and Asian populations. METHODS: Analyses were based on the Asia Pacific Cohort Studies Collaboration of 506 648 study participants (408 381 Asia, 98 267 Australasia) drawn from 38 population-based cohort studies. Cox proportional hazards regression was used to estimate the relationship between height and cancer rates. RESULTS: A total of 3 272 600 person-years of follow-up gave rise to 7497 cancer deaths (4415 in Asia; 3082 in Australasia). After multiple adjustments and left censoring, taller individuals experienced increased rates of carcinoma of the intestine (men and women); all cancers, liver, lung, breast, 'other' malignancies (all women); and cancers of the prostate and bladder (men). No consistent regional (Asia versus Australasia) or sex differences were observed. CONCLUSIONS: In the present study, taller men and women had an elevated risk of selected malignancies. These associations did not differ appreciably between Asian and Caucasian populations.
Authors: M Woodward; F Barzi; A Martiniuk; X Fang; D F Gu; Y Imai; T H Lam; W H Pan; A Rodgers; I Suh; S H Jee; H Ueshima; R Huxley Journal: Int J Epidemiol Date: 2006-10-22 Impact factor: 7.196
Authors: G Davey Smith; C Hart; M Upton; D Hole; C Gillis; G Watt; V Hawthorne Journal: J Epidemiol Community Health Date: 2000-02 Impact factor: 3.710
Authors: Andrew G Renehan; Marcel Zwahlen; Christoph Minder; Sarah T O'Dwyer; Stephen M Shalet; Matthias Egger Journal: Lancet Date: 2004-04-24 Impact factor: 79.321
Authors: R Huxley; K Jamrozik; T H Lam; F Barzi; A Ansary-Moghaddam; C Q Jiang; I Suh; M Woodward Journal: Am J Epidemiol Date: 2007-03-16 Impact factor: 4.897
Authors: Bryan B Shapiro; Elani Streja; Vanessa A Ravel; Kamyar Kalantar-Zadeh; Joel D Kopple Journal: Clin J Am Soc Nephrol Date: 2015-03-30 Impact factor: 8.237
Authors: Albina N Minlikeeva; Kirsten B Moysich; Paul C Mayor; John L Etter; Rikki A Cannioto; Roberta B Ness; Kristen Starbuck; Robert P Edwards; Brahm H Segal; Sashikant Lele; Kunle Odunsi; Brenda Diergaarde; Francesmary Modugno Journal: Cancer Causes Control Date: 2018-01-11 Impact factor: 2.506
Authors: Cari M Kitahara; Sophia S Wang; Beatrice S Melin; Zhaoming Wang; Melissa Braganza; Peter D Inskip; Demetrius Albanes; Ulrika Andersson; Laura E Beane Freeman; Julie E Buring; Tania Carreón; Maria Feychting; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Goran Hallmans; Susan E Hankinson; Roger Henriksson; Ann W Hsing; Christoffer Johansen; Martha S Linet; Roberta McKean-Cowdin; Dominique S Michaud; Ulrike Peters; Mark P Purdue; Nathaniel Rothman; Avima M Ruder; Howard D Sesso; Gianluca Severi; Xiao-Ou Shu; Victoria L Stevens; Kala Visvanathan; Martha A Waters; Emily White; Alicja Wolk; Anne Zeleniuch-Jacquotte; Wei Zheng; Robert Hoover; Joseph F Fraumeni; Nilanjan Chatterjee; Meredith Yeager; Stephen J Chanock; Patricia Hartge; Preetha Rajaraman Journal: Int J Epidemiol Date: 2012-08 Impact factor: 7.196